journal article·2019-12-04Open access

Emodin protects against lipopolysaccharide-induced inflammatory injury in HaCaT cells through upregulation of miR-21

Yanping Song, Xueling Cui, Ruilan Zhao, Lanying Hu, Yanjun Li, Cuiling Liu

Abstract

Background/aim Pressure ulcers are a disastrous health issue in which inflammation is involved. Emodin possesses biological properties in inflammation. Our study investigated functions of emodin in lipopolysaccharide (LPS)-treated HaCaT cells.Methods LPS was used to induce cell inflammation. MTT and flow cytometry were applied for cell viability and apoptosis assays, respectively. Moreover, apoptotic proteins were detected by western blot. Similarly, inflammatory factors and signalling related proteins were also determined by western blot.Results Emodin increased cell viability and diminished apoptosis in LPS-treated HaCaT cells. Moreover, cleaved-PARP, cleaved-caspase-3 and cleaved-caspase-9 were all downregulated by emodin. Furthermore, inflammatory factors IL-1β, IL-6, Cox-2 and iNOS were inhibited by emodin in LPS-treated cells. In addition, emodin decreased phosphorylation of p65 and IκBα and the level of PTEN while enhanced phosphorylation of PI3K and AKT. Importantly, emodin increased expression of miR-21 suppressed by LPS and miR-21 downregulation negated the protective functions of emodin.Conclusions Emodin promoted cell growth presented by increasing viability and blocking apoptosis process with inflammation inhibition. The protective activity of emodin was mediated by miR-21 up-regulation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Phytochemistry and biological activity of medicinal plants · Pressure Ulcer Prevention and Management · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Health Management, Heze Medical College

Department of Breast and Thyroid Surgery, Heze Municipal Hospital

Department of General Medicine, Heze Municipal Hospital

Department of Joint Surgery, Heze Municipal Hospital

Department of Nursing, Heze Medical College

References (44)

Show source-provided references
1. McInnes E, Jammali-Blasi A, Bell-Syer SE, et al. Support surfaces for pressure ulcer prevention. Cochrane Database Syst Rev. 2015;3:CD001735.
2. 10.1016/j.ijnurstu.2015.06.00610.1016/j.ijnurstu.2015.06.006 ↗
3. 10.1016/S0749-0690(18)30152-610.1016/S0749-0690(18)30152-6 ↗
4. Moore ZE, Cowman S. Risk assessment tools for the prevention of pressure ulcers. Cochrane Database Syst Rev. 2008;3:CD006471.
5. 10.12659/MSM.89703210.12659/MSM.897032 ↗
6. 10.1016/j.jdermsci.2016.03.01210.1016/j.jdermsci.2016.03.012 ↗
7. 10.1111/j.1742-481X.2012.00969.x10.1111/j.1742-481X.2012.00969.x ↗
8. 10.1186/s13020-017-0158-510.1186/s13020-017-0158-5 ↗
9. 10.1016/j.apjtm.2015.09.01110.1016/j.apjtm.2015.09.011 ↗
10. Aly MM, Gumgumjee NM. Antimicrobial efficacy of Rheum palmatum, Curcuma longa and Alpinia officinarum extracts against some pathogenic microorganisms. Afr J Biotechnol. 2011;10:12058–12063.
11. 10.1093/rheumatology/ket17810.1093/rheumatology/ket178 ↗
12. 10.1016/j.resp.2015.05.00610.1016/j.resp.2015.05.006 ↗
13. 10.1007/s10753-013-9634-y10.1007/s10753-013-9634-y ↗
14. 10.1016/j.biopha.2016.10.03110.1016/j.biopha.2016.10.031 ↗
15. 10.1007/978-1-4939-6524-3_110.1007/978-1-4939-6524-3_1 ↗
16. 10.1159/00048595210.1159/000485952 ↗
17. Yang R, Han L, Zeng X. A functional polymorphism at miR4915p binding site in the 3'UTR of MMP9 gene confers increased risk for pressure ulcers after hip fracture. Oncol Rep. 2018;39:2695–2702.
18. 10.1016/j.yexmp.2018.12.00510.1016/j.yexmp.2018.12.005 ↗
19. 10.1189/jlb.4A1014-489R10.1189/jlb.4A1014-489R ↗
20. 10.3389/fimmu.2015.0001910.3389/fimmu.2015.00019 ↗
21. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
22. 10.1186/1742-2094-7-3010.1186/1742-2094-7-30 ↗
23. 10.1016/j.phymed.2016.03.01610.1016/j.phymed.2016.03.016 ↗
24. 10.1002/ptr.563110.1002/ptr.5631 ↗
25. 10.1016/j.lfs.2018.05.05710.1016/j.lfs.2018.05.057 ↗
26. 10.1016/j.cytogfr.2019.03.00110.1016/j.cytogfr.2019.03.001 ↗
27. 10.1016/j.intimp.2016.02.01410.1016/j.intimp.2016.02.014 ↗
28. 10.1248/bpb.b15-0103710.1248/bpb.b15-01037 ↗
29. 10.1590/1414-431x2016579410.1590/1414-431x20165794 ↗
30. 10.1111/rda.1254910.1111/rda.12549 ↗
31. 10.1016/j.fct.2018.03.03910.1016/j.fct.2018.03.039 ↗
32. 10.1016/j.neulet.2016.06.03610.1016/j.neulet.2016.06.036 ↗
33. 10.1016/j.canlet.2013.08.02310.1016/j.canlet.2013.08.023 ↗
34. 10.1016/j.jep.2014.03.05910.1016/j.jep.2014.03.059 ↗
35. 10.1111/j.1476-5381.2010.00993.x10.1111/j.1476-5381.2010.00993.x ↗
36. 10.3390/ijms15111935510.3390/ijms151119355 ↗
37. 10.1177/153473541666478410.1177/1534735416664784 ↗
38. 10.4049/jimmunol.080356010.4049/jimmunol.0803560 ↗
39. 10.1016/j.brainres.2014.07.04510.1016/j.brainres.2014.07.045 ↗
40. 10.3109/10715762.2013.86583910.3109/10715762.2013.865839 ↗
41. 10.1007/s13277-016-5074-210.1007/s13277-016-5074-2 ↗
42. 10.1038/emm.2015.3610.1038/emm.2015.36 ↗
43. 10.3389/fimmu.2017.0148810.3389/fimmu.2017.01488 ↗
44. 10.3892/mmr.2015.415810.3892/mmr.2015.4158 ↗